Company

MEI Pharma, Inc.

MEI Pharma develops cancer therapies targeting treatment resistance.

About

Founded in 2000 and based in San Diego, US, MEI Pharma develops oncology therapies for hematologic malignancies and solid tumors. Its pipeline includes Voruciclib, which is in clinical trials. The company has raised USD 75.00 mn across 7 deals; its latest PIPE round was led by CAM Capital and Vivo Capital. Its CEO team includes Dan Gold, David Urso, and Matheno Bey.

2Funding rounds

5Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in